Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission ...

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The ...

The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.

The pharmaceutical sector is highly regulated, as it should be, given the direct impact on lives involved with medical care.

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis: Taiwan Tuesday, January 6, 2026, 14:00 Hrs [IST] ScinoPharm Taiwan, a professiona ...

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers ...

A bankruptcy filing by Israeli cultivated meat firm Believer Meats sheds light on how approval delays stalled its fundraising ...

Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...

Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...